| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
Digg It - Assessing Value
A client of ours recently asked us to help his company increase sales revenue. "Our sales are okay, but not what we need them According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product to be," he said. "I just have to believe we could be closing more business. Once we get in the door, the sales process goes ve ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in y well. It's getting in that's the problem." What else is new? Many companies have the goal of sustaining existence by selli lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. g what they make. Great companies focus on delivering unique value -- even before a single product or service is purchased. It here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe s an old saw that is still ignored by far too many businesses. Our client's problem is simple: His company fails to communica d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e unique value to the target market. Lifeblood Communication is the lifeblood of every business. It carries unique va ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ue -- the key nutrient that feeds all relationships. When the flow of value is obstructed, a variety of symptoms manifest, inc easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi luding:
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically sing the flow of communication is one of the most important business diagnostics tools available to you. One method of assessi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ g that flow is by analyzing the value delivered to key stakeholders. In our client's case, a business communications assessme ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi t of marketing collateral revealed that the language the company used to talk about its value and the customer's perception of ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a the company's value did not match up. Unique value in this case was obscured by heavy language: Jargon, thick wording, and phr dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod sing designed to sound good rather than convey information. The material put people off. Because it was so difficult to under cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin tand, there was no value flow. When value doesn't flow outward from a business, value (money) doesn't flow in. Relationships s tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen tagnate. Nobody wins. The Flow of Value Value flow is always bidirectional in relationships. Otherwise all you're do t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ng is broadcasting. Restrictions in the flow of value cause poor business health. Many a business has closed its doors because ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust value flow stopped. As you watch the flow of value in your business, think about the relationship between what your organizat y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products on gives and what it receives. Turn that relationship around and study your customers until you are as clear about what value . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de eans for them as you are about what it means for you. When you learn to perceive your unique value from the customer's perspe elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tive, your communication into the marketplace reflects that perception. Your business cannot help but be healthier as a result tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Moving Toward A Paperless Office The Real Big Picture Around Options Backdating Checklist and Tips for Selling a Business
|